longbridgelongbridge
  • Platform Features
    Features
    Investment ProductsPrivate Wealth ManagementTrading ToolsMarket Data ServicesAnalysis ToolsNews ServicesFor Developers
    Account Types
    For IndividualsFor Institutions
  • Café
longbridge
© 2026 Longbridge|Terms of ServicePrivacy Policy

Milestone Scientific

MLSS

----
Start trading
OverviewOverviewNewsNewsPostsPostsFinancialsFinancialsForecastForecastValuationValuationShareholdersShareholdersProfileProfile
LongbridgeAI

Current ValuationThe current P/E ratio is -8.69, below the reasonable range, cheaper than 85.82% of the time in the past 1 years, and the industry ranks 128/175, the industry Median -0.92.

-8.69xP/E
$0.40Stock price
$-0.05Earnings per share
-8.69xP/E
Stock price$0.40Earnings per share$-0.05

Historical Valuation

P/E ratioTypical rangeMedian
P/E ratio
-4.90x
Typical range
-8.14x–-3.44x

Peer P/E ratio Comparison

It displays how the company's P/E ratio compares to top companies within its industry.
012243648

The industry median valuation is currently at or below 0 and may not serve as a meaningful benchmark.

Industry P/E ratio Comparison

This shows the distribution of companies by P/E ratio range and their projected earnings per share growth for the next fiscal year.
0x30x60x90x120x150x
P/E ratio
Name/Symbol
BAXUSBaxter
-11.52x141.71%$12.24B
GKOSUSGlaukos
-50.14x75.37%$9.43B
TFXUSTeleflex
-5.13x118.39%$5.29B
PLSEUSPulse Biosciences
-46.94x27.55%$3.76B
IRTCUSIRhythm
-261.23x71.96%$3.64B
BFLYUSButterfly Network
-35.33x34.41%$2.64B
AXGNUSAxogen
-77.90x31.25%$2.61B
ASSTUSStrive
-2.08x63.23%$2.03B
NVCRUSNovocure
-13.07x2.52%$1.94B
ATECUSAlphatec
-14.51x41.67%$1.60B
KMTSUSKestra Medical Tech
-10.20x0.94%$1.53B
DRTSUSAlpha Tau Medical
-15.10x--$1.40B
IARTUSIntegra LifeSciences
-172.16x109.50%$1.25B
TNDMUSTandem Diabetes
-19.23x77.82%$1.22B
BBNXUSBeta Bionics
-16.45x14.28%$1.20B
AORTUSArtivion
-368.69x266.67%$1.18B
ENOVUSEnovis
-0.96x100.97%$1.06B
PRCTUSPROCEPT BioRobotics
-9.62x3.47%$1.06B
CBLLUSCeribell
-14.10x35.15%$930.67M
SIBNUSSI-BONE
-57.62x8.85%$843.04M

Risk Warning

Timeframes using financial data from S&P Global. The feature provides key metrics such as price-to-earnings (P/E), price-to-book (P/B), price-to-sales (P/S) ratios, and dividend yield. For reference only and does not constitute investment advice.